Today there was a lawsuit settlement reached between Pfizer and the U.S. Department of Justice in regard to marketing practices that the company used in promoting Bextra. Phizer settlement also includes and agreement with attorneys general in 42 states and the District of Columbia to settle another lawsuit Geodon.
Get the full story...
Talk show host Jon Stewart is slamming reports that beleaguered drugmaker Pfizer Inc. is in talks to acquire Preparation H-maker Wyeth for $60 billion.
Get the full story...
According to reports, Pfizer is in talks to acquire rival drug maker Wyeth. The merger deal could be worth more than $60 billion, according to sources close to the matter.
Get the full story...
New York-based drug firm Pfizer Inc. has locked down their Chesterfield campus, near St. Louis, after a lunchtime shooting.
Get the full story...
A strong signal of multiple safety problems with Chantix (varenicline), a drug to help people stop smoking, has been seen in a pilot program to identify new drug risks in adverse drug events reported to the U.S. Food and Drug Administration.
Get the full story...
In a move to bolster its cancer treatment drug supply Pfizer said that it has reached a deal with Serenex to buy the pharmaceutical drug company.
Get the full story...
Pfizer, which is the pharmaceutical company behind the drug Viagra is set to cut 420 jobs as it ends manufacturing operation in Kent, United Kingdom.
Get the full story...
Pfizer Reconfirms Full-Year 2007 and 2008 Financial Guidance and Updates Progress on Immediate Business Priorities
Get the full story...
Pfizer Also Announces Resignation of Chief Financial Officer Alan Levin, Who Will Continue as CFO Until Successor is Named
Get the full story...
"Worldwide pharmaceutical 2006 revenues met our expectations," said Ian Read, President of Worldwide Pharmaceutical Operations at Pfizer. "We focused on the top-line growth of key in-line medicines, including Lipitor, Celebrex, Lyrica, and Geodon, and we launched Sutent, Eraxis, Chantix, and Exubera in the U.S."
Read the full story